Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
2009 · Journal of Hematology & Oncology · 62 citations
https://doi.org/10.1186/1756-8722-2-20